We are monitoring the impact of COVID-19 on MEA Cancer Immunotherapy Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1341
Share on
Share on

Middle East & Africa Cancer Immunotherapy Market Research Report – Segmented By Application, Product Type, Mode Of Administration, End Users, Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends, Forecast | 2020 to 2025

Pulished: February, 2020
ID: 1341
Pages: 132

MEA Cancer Immunotherapy Market Size (2020 to 2025)

The Cancer Immunotherapy Market size in Middle East & Africa was worth USD 4.83 Billion in 2020 and estimated to reach USD 8.25 Billion by the end of 2025, with a growing potential of 11.35 %.

Immunotherapy is a class of cancer treatment that works to harness the powers of the immune system to fight against cancer. Because of the unique properties of the immune system, these therapies may hold more enormous potential than other treatment approaches to fight cancer more powerfully, to offer longer-term protection against the disease, to come with lesser side effects, and to benefit more patients with more cancer types.

The factors that are driving the growth of the Middle East and Africa immunotherapy market are increasing occurrence of cancer, Changing lifestyle, Smoking and excessive alcohol intake, high efficacy of immunotherapy compared to other treatments, fewer side effects associated with cancer immunotherapy, reduced chance of recurrence of cancer.

Various cancers like Melanoma shows resistance towards chemotherapy and radiation therapies, Cost of cancer therapies, limited information on cancer immunobiology are the major factors restricting the growth of the market.

This research report has been segmented & sub-segmented into the following categories:

  • By Type of Therapies: Immune System Modulators, Immune Checkpoint Inhibitors & Monoclonal Antibodies
  • By Area of Therapy: Blood Cancer, Prostate Cancer, Melanoma, Breast Cancer, Lung Cancer, Colorectal Cancer & Other Minor Areas
  • By Country: KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Prominent companies in the MEA cancer immunotherapy Market are F. Hoffmann-La Roche Ltd, Amgen, Viralytics, Novartis Pharmaceuticals Corporation, Pfizer, GlaxoSmithKline Pharmaceuticals Limited, AstraZeneca plc, Medivation, Advaxis, Bristol-Myers Squibb, Merck & Co. and Celgene Corp, Immunomedics.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 Breast       

                                5.1.3 Lung          

                                5.1.4 Melanoma              

                                5.1.5 Colorectal

                                5.1.6 Head & Neck          

                                5.1.7 Prostate   

                                5.1.8 Others      

                                5.1.9 Y-o-Y Growth Analysis, By Application         

                                5.1.10 Market Attractiveness Analysis, By Application     

                                5.1.11 Market Share Analysis, By Application      

                5.2 Product Type                             

                                5.2.1 Introduction           

                                5.2.2 Monoclonal Antibodies     

                                5.2.3 Checkpoint inhibitors/immune modulators              

                                5.2.4 Therapeutic cancer vaccines            

                                5.2.5 Oncolytic virus immunotherapy     

                                5.2.6 Cytokines

                                5.2.7 Adoptive T cell transfer     

                                5.2.8 Adjuvant Immunotherapy

                                5.2.9 Interferons             

                                5.2.10 Interleukins         

                                5.2.11 BCG         

                                5.2.12 Others   

                                5.2.13 Y-o-Y Growth Analysis, By Product Type   

                                5.2.14 Market Attractiveness Analysis, By Product Type

                                5.2.15 Market Share Analysis, By Product Type  

                5.3 Mode of Administration                        

                                5.3.1 Introduction           

                                5.3.2 Intravenous           

                                5.3.3 Oral            

                                5.3.4 Topical      

                                5.3.5 Intra Vesical           

                                5.3.6 Y-o-Y Growth Analysis, By Mode of Administration

                                5.3.7 Market Attractiveness Analysis, By Mode of Administration              

                                5.3.8 Market Share Analysis, By Mode of Administration

                5.3 End users                    

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Y-o-Y Growth Analysis, By End users            

                                5.3.5 Market Attractiveness Analysis, By End users           

                                5.3.6 Market Share Analysis, By End users            

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Product Type

                                                6.1.3.4 By Mode of Administration

                                                6.1.3.5 By End users

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Product Type

                                                6.1.4.4 By Mode of Administration

                                                6.1.4.5 By End users

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Product Type

                                                6.1.5.4 By Mode of Administration

                                                6.1.5.6 By End users

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 F. Hoffmann-La Roche Ltd                    

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Amgen                         

                8.3 Viralytics                      

                8.4 Novartis Pharmaceuticals Corporation                            

                8.5 Pfizer                            

                8.6 GlaxoSmithKline Pharmaceuticals Limited                     

                8.7 AstraZeneca plc                        

                8.8 Medivation                

                8.9 Advaxis                        

                8.10 Bristol-Myers Squibb                           

                8.11 Merck & Co. and Celgene Corp                        

                8.12 Immunomedics                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Cancer Immunotherapy Market By Application, From 2020 to 2025 (USD Billion)
  2. Middle East & Africa Breast Market By Region, From 2020 to 2025 (USD Billion)
  3. Middle East & Africa Lung Market By Region, From 2020 to 2025 (USD Billion)
  4. Middle East & Africa Melanoma Market By Region, From 2020 to 2025 (USD Billion)
  5. Middle East & Africa Colorectal Market By Region, From 2020 to 2025 (USD Billion)
  6. Middle East & Africa Head & Neck Market By Region, From 2020 to 2025 (USD Billion)
  7. Middle East & Africa Prostate Market By Region, From 2020 to 2025 (USD Billion)
  8. Middle East & Africa Cancer Immunotherapy Market By Product Type, From 2020 to 2025 (USD Billion)
  9. Middle East & Africa Monoclonal Antibodies Market By Region, From 2020 to 2025 (USD Billion)
  10. Middle East & Africa Checkpoint inhibitors/immune modulators Market By Region, From 2020 to 2025 (USD Billion)
  11. Middle East & Africa Therapeutic cancer vaccines Market By Region, From 2020 to 2025 (USD Billion)
  12. Middle East & Africa Oncolytic virus immunotherapy Market By Region, From 2020 to 2025 (USD Billion)
  13. Middle East & Africa Cytokines Market By Region, From 2020 to 2025 (USD Billion)
  14. Middle East & Africa Adoptive T cell Transfer Market By Region, From 2020 to 2025 (USD Billion)
  15. Middle East & Africa Adjuvant immunotherapy Market By Region, From 2020 to 2025 (USD Billion)
  16. Middle East & Africa Interferons Market By Region, From 2020 to 2025 (USD Billion)
  17. Middle East & Africa Interleukins Market By Region, From 2020 to 2025 (USD Billion)
  18. Middle East & Africa BCG Market By Region, From 2020 to 2025 (USD Billion)
  19. Middle East & Africa Cancer Immunotherapy Market By Mode of Administration, From 2020 to 2025 (USD Billion)
  20. Middle East & Africa Intravenous Market By Region, From 2020 to 2025 (USD Billion)
  21. Middle East & Africa Oral Market By Region, From 2020 to 2025 (USD Billion)
  22. Middle East & Africa Topical Market By Region, From 2020 to 2025 (USD Billion)
  23. Middle East & Africa Intravesical Market By Region, From 2020 to 2025 (USD Billion)
  24. Middle East & Africa Cancer Immunotherapy Market By End users, From 2020 to 2025 (USD Billion)
  25. Middle East & Africa hospitals Market By Region, From 2020 to 2025 (USD Billion)
  26. Middle East & Africa Clinics Market By Region, From 2020 to 2025 (USD Billion)
  27. Middle East Cancer Immunotherapy Market By Application, From 2020 to 2025 (USD Billion)
  28. Middle East Cancer Immunotherapy Market By Product Type, From 2020 to 2025 (USD Billion)
  29. Middle East Cancer Immunotherapy Market By Mode of Administration, From 2020 to 2025 (USD Billion)
  30. Middle East Cancer Immunotherapy Market By End users, From 2020 to 2025 (USD Billion)
  31. Africa Cancer Immunotherapy Market By Application, From 2020 to 2025 (USD Billion)
  32. Africa Cancer Immunotherapy Market By Product Type, From 2020 to 2025 (USD Billion)
  33. Africa Cancer Immunotherapy Market By Mode of Administration, From 2020 to 2025 (USD Billion)
  34. Africa Cancer Immunotherapy Market By End users, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample